Piperazine drug data and news

Piperazine drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Piperazine
Brand Names/Synonyms Anatensol; Antepan; Antepar; Antiren; Asca-Trol No. 3; Bryrel; Dapotum; Diethylenediamine; Diethyleneimine; Dispermine; Entacyl; Eraverm; Fluphenazine Dihydrochloride; Hexahydropyrazine; Lumbrical; Lyogen; Moditen; Multifuge; Omca; Pacinol; Permitil; Piperazidine; Piperazin; Piperazine; Piperazine Anhydrous; Piperazine Citrate; Piperazine, Anhydrous; Pipersol; Prolixin Decanoate; Pyrazine Hexahydride; Pyrazine, Hexahydro-; Siqualone; Tasnon; Tensofin; UN 2579; Upixon; Uvilon; Valamina; Vermex; Vermidol; Worm-Away; Wurmirazin
Indication Used as alternative treatment for ascariasis caused by Ascaris lumbricoides(roundworm) and enterobiasis (oxyuriasis) caused by Enterobius vermicularis (pinworm).
Sponsored links
Description Not Available
Pharmacology Piperazine is an antinematodal agent indicated as alternative treatment for ascariasis caused by Ascaris lumbricoides (roundworm) and enterobiasis (oxyuriasis) caused by Enterobius vermicularis (pinworm). Piperazine is especially useful in the treatment of partial intestinal obstruction caused by Ascaris worms, which is a condition primarily seen in children.
Mechanism Of Action Piperazine is a GABA receptor agonist. Piperzine binds directly and selectively to muscle membrane GABA receptors, presumably causing hyperpolarization of nerve endings, resulting in flaccid paralysis of the worm. While the worm is paralyzed, it is dislodged from the intestinal lumen and expelled live from the body by normal intestinal peristalsis.
Piperazine News
(When available)

ImQuest Pharmaceuticals Licenses Piperazine Series of Anti-Cancer ...  Apr 26, 2006
The piperazine series has been shown in both cell based and small animal model anti-cancer studies performed by the National Cancer Institute (NCI, USA) and ... - Yahoo! News (press release)

Side-effect warning on BZP-based ‘party pills’  Apr 17, 2006
The National Poisons Centre predicts that doses over a total of 250mg of a piperazine-based designer drug would likely cause moderate toxicity, such as anxiety ... - Gisborne Herald,

ImQuest licenses anticancer compounds from Samjin  Apr 27, 2006
The piperazine series has been shown in both cell-based and small animal model anticancer studies to have significant and diverse biological anti-tumor ... - Pharmaceutical Business Review

Dosage Forms CAPSULE; DROPS; LIQUID; POWDER; POWDER FOR SOLUTION; SOLUTION; SUSPENSION; SYRUP; TABLET
Drug_Category Antinematodal Agents; Anthelmintics; ATC:P02CB01; ATC:R03DA09
Absorption Rapidly absorbed from the gastrointestinal tract
Interactions Not Available
Toxicity LD50 = 5 g/kg (Human, oral)
Organisms Affected Parasitic nematodes and other roundworms
Chemical IUPAC Name piperazine
Chemical Formula C4H10N2
Molecular Weight 86.1357 g/mol
Smiles String C1CNCCN1
Melting Point 106 °C
Water Solubility 150 mg/mL
State Solid
LogP/Hphobicity -0.836
Isoelectric Point 9.73
Biotransformation About 25% is metabolized in the liver
Half Life Not Available
Protein Binding [%] 60-70%
RxList Link Not Available>RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Piperazine.html
http://www.pharmgkb.org/views/index.jsp?objId=
Drug Type Approved Drug
Accession No APRD00225
CAS Registry Number 110-85-0
KEGG Compound ID C07973
PubChem ID SID:261079
PharmGKB ID PA450977
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] 97128

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org